Effects of rolipram on the elevated plus-maze test in rats: A preliminary study

Journal of Psychopharmacology

Volumn 13, Issue 3, 1999, Pages 274-277

  Silvestre, Jordi S ^a,b   Fernández, Andrés G ^a   Palacios, José M ^a  

^a Almirall Prodesfarma ^*  (Spain)

^b PROUS SCIENCE   (Spain)

Author keywords

Anxiety; Behaviour; Diazepam; Elevated plus maze; Imipramine; Rat; Rolipram

Indexed keywords

DIAZEPAM; IMIPRAMINE; ROLIPRAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY;

EID: 0345061672     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300309     Document Type: Article

References (28)

1. Blanchard R J, Shepherd J K, Rodgers R J, Magee L, Blanchard D C (1993) Attenuation of antidepredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology 110: 245-253
2. Bobon D, Breulet M, Gerard-Vandenhove M-A, Guiot-Goffioul F, Plomteux G, Sastre-y-Hernández M, Schratzer M, Troisfontaines B, von Frenckell R, Wachtel H (1988) Is phosphodiesterase inhibition a new mechanism of antidepressant action? Eur Arch Psychiat Neurol Sci 238: 2-6
3. Criswell H E, Knapp D J, Overstreet D H, Breese G R (1994) Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity. Alcohol Clin Exp Res 18: 596-601
4. 2 receptors. Psychopharmacology 93: 502-506
5. Cruz A P M, Frei F, Graeff F G (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49: 171-176
6. Dawson G R, Tricklebank M D (1995) Use of the elevated plus maze in the search for novel anxiolytic agents. TIPS 16: 33-36
7. 1A receptor agonists and NMDA antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169: 1-10
8. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99: 248-251
9. Gao B, Cutler M G (1994) Effects of acute and chronic administration of antidepressants, imipramine, phenelzine and mianserine, on the social behavior of mice. Neuropharmacology 33: 813-824
10. Griebel G, Misslin R, Vogel E, Bourguingnon J-J (1991) Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors. Pharmacol Biochem Behav 39: 321-323
11. Griebel G, Blanchard D C, Agnes R S, Blanchard R J (1995) Differential modulation of antidepredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 120: 57-66
12. Heaslip R J, Evans D Y (1995) Emetic, central nervous system, and pulmonary activities of rolipram in the dog. Eur J Pharmacol 286: 281-290
13. Horowski R, Sastre-y-Hernandez M (1985) Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports, Curr Ther Res 38: 23-29
14. Imaizumi M, Miyazaki S, Onodera K (1994) Effects of a non-xanthine adenosine antagonist, CGS15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice. Meth Find Exp Clin Pharmacol 16: 717-721
15. Kehr W, Debus G, Neumeister R (1985) Effects of rolipram, a novel antidepressant on monoamine metabolism in rat brain. J Neural Transm 63: 1-12
16. Moser P C (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99: 48-53
17. Nicholson C D, Challis R A J, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. TIPS 12: 19-27
18. O'Neill M F, Fernández A G, Palacios J M (1996) GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacol Biochem Behav 53: 535-539
19. Pellow S, Chopin P, File S E, Briley M (1985) Validation of open, closed arms entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14: 149-167
20. Porsolt R D, Lengre A, McArthur R A (1991) Pharmacological models of depression. In Animal models in Psychopharmacology: advances in pharmacological sciences. Birkhäuser Verlag Basel, pp. 137-159
21. Schneider H H (1984) Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochem Pharmacol 33: 1690-1693
22. Schneider H H, Schmiechen R, Brezinski M, Seidler J (1986) Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur J Pharmacol 127: 105-115
23. Silvestre J S, Fernández A G, Palacios J M (1999) Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram. Pharmacol Biochem Behav (in press).
24. Wachtel H (1982) Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology 77: 309-316
25. Wachtel H (1983) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22: 267-272
26. Wachtel H (1990) The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry 23: 27-32
27. Wachtel H, Schneider H H (1986) Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology 25: 1119-1126
28. Willard M, Misslin R, Vogel E, Desaubry L, Wermuth C, Bourguignon J-J (1990) Anxiolytic and sedative properties of BW A78U, a novel anticonvulsant adenine derivate. Pharmacol Biochem Behav 35: 85-88